Identifying the facilitators and barriers for scientific writing among pharmacy students in College of Pharmacy, Umm Al-Qura University - A qualitative study.

INTRODUCTION: English is the dominant international language for academic publication, thus mastering English writing is required for a successful career in research. Our objective was to identify facilitators and barriers to English language scientific writing among pharmacy students in Umm Al-Qura University in Saudi Arabia (where English is not the native language). METHODS: We used face-to-face semi-structured interviews in the Arabic language with fourth- and fifth-year students of the college to gain insight into their perspectives. An interview guide was prepared using the Arabic language. The interviews were conducted at the college of pharmacy. All interviews were recorded and transcribed verbatim. RESULTS: Twenty-three participants agreed to be interviewed and signed the consent form. The mean interview time was 10 min. Two researchers independently analyzed the qualitative data using thematic analysis and agreed on the coding and themes. A third researcher verified the themes on randomly selected transcripts. The analysis showed main facilitator themes of: having rich vocabulary, competency in English language, having new ideas, increased writing activities, and individual guidance. Barrier themes were: lack of vocabulary, incompetency in English language, time constraint, lack of ideas, lack of writing activities, and lack of guidance. CONCLUSIONS: Participants of this study showed limited understanding of scientific writing. This study also found that pharmacy students need to develop their writing skills through practice sessions and university courses.

The impact of pharmacists-led medicines reconciliation on healthcare outcomes in secondary care: A systematic review and meta-analysis of randomized controlled trials.

BACKGROUND: Adverse drug events (ADEs) impose a major clinical and cost burden on acute hospital services. It has been reported that medicines reconciliation provided by pharmacists is effective in minimizing the chances of hospital admissions related to adverse drug events. OBJECTIVE: To update the previous assessment of pharmacist-led medication reconciliation by restricting the review to randomized controlled trials (RCTs) only. METHODS: Six major online databases were sifted up to 30 December 2016, without inception date (Embase, Medline Ovid, PubMed, BioMed Central, Web of Science and Scopus) to assess the effect of pharmacist-led interventions on medication discrepancies, preventable adverse drug events, potential adverse drug events and healthcare utilization. The Cochrane tool was applied to evaluate the chances of bias. Meta-analysis was carried out using a random effects model. RESULTS: From 720 articles identified on initial searching, 18 RCTs (6,038 patients) were included. The quality of the included studies was variable. Pharmacists-led interventions led to an important decrease in favour of the intervention group, with a pooled risk ratio of 42% RR 0.58 (95% CI 0.49 to 0.67) P<0.00001 in medication discrepancy. Reductions in healthcare utilization by 22% RR 0.78 (95% CI 0.61 to 1.00) P = 0.05, potential ADEs by10% RR 0.90 (95% CI 0.78 to 1.03) P = 0.65 and preventable ADEs by 27% RR 0.73 (0.22 to 2.40) P = 0.60 were not considerable. CONCLUSION: Pharmacists-led interventions were effective in reducing medication discrepancies. However, these interventions did not lead to a significant reduction in potential and preventable ADEs and healthcare utilization.